NCT01376401 - Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2015

Conditions

Multiple Myeloma

Interventions

DRUG

Bendamustine

DRUG

Velcade

DRUG

Prednisone

Trial Locations (14)

Hospital Germans Trias i Pujol, Badalona

Hospital Clínic, Barcelona

Institut català d'Oncología, Barcelona

Hospital 12 de Octubre, Madrid

Hospital Clínico San Carlos, Madrid

Hospital Universitario de la Princesa, Madrid

Hospital Universitario Ramón y Cajal, Madrid

MD Anderson Internacional, Madrid

Hospital Universitario Virgen de la Victoria, Málaga

Hospital General Morales Messeguer, Murcia

Hospital Universitario Central de Asturias, Oviedo

Hospital Universitario Virgen del Rocío, Seville

Hospital Universitario La Fe, Valencia

Hospital Clinico Universitario Lozano Blesa, Zaragoza